Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03285529 · ClinicalTrials.gov registry record · NA
The Use of STRATAFIX Suture Device Compared to Standard-of-care for Deep Tissue Closure in Total Knee Arthroplasty
A NA study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT03285529 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 60 participants.
The verdict
NCT03285529, a NA study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The STRATAFIX (Ethicon, Johnson and Johnson, Somerville, New Jersey) Knotless Tissue Control suture device is a barbed suture that uses anchor technology to securely engage with the soft tissues while also eliminating the need for knots. The anchors, or barbs, are pressed out of the device core or formed within the core in a geometric pattern and arranged in a tapered manner to allow the device to pass through tissue in the direction toward the needle during closure. These knotless tissue control devices are deployed using a continuous technique, which is anticipated to be faster and more cost-effective than interrupted suturing.
Interventions
- DEVICE STRATIFIX
- DEVICE VICRYL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2017-09-26 |
| Est. Completion | 2019-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03285529
The ClinicalTrials.gov registry entry for NCT03285529 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which STRATIFIX is the first listed.
NCT03285529 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03285529 about?
NCT03285529 is a clinical study titled "The Use of STRATAFIX Suture Device Compared to Standard-of-care for Deep Tissue Closure in Total Knee Arthroplasty". The STRATAFIX (Ethicon, Johnson and Johnson, Somerville, New Jersey) Knotless Tissue Control suture device is a barbed suture that uses anchor technology to securely engage with the soft tissues while also eliminating the need for knots. The anchors, or barbs, are pressed out of the device core or f...
What is the current status of trial NCT03285529?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2017-09-26. Estimated completion is 2019-05-31.
What interventions are being tested in trial NCT03285529?
The interventions under investigation include: STRATIFIX (DEVICE), VICRYL (DEVICE).
Who is sponsoring clinical trial NCT03285529?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.